# FDA recall D-1190-2022

> **SUN PHARMACEUTICAL INDUSTRIES INC** · Class II · drug recall initiated 2022-06-21.

## Product

Testosterone Cypionate Injection, USP, 200mg/mL, CIII,  Rx only, 1mL Single-dose vial, Distributed by:  Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceuticals Industries Ltd.,  Halol- Baroda Highway, Halol-Baroda, Highway, Halol- 389 350, Gujarat, India, NDC 62756-015-40.

## Reason for recall

cGMP - Water leakage

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-1190-2022
- **Recalling firm:** SUN PHARMACEUTICAL INDUSTRIES INC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-06-21
- **Report date:** 2022-07-20
- **Termination date:** 2023-05-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1190-2022

## Citation

> AI Analytics. FDA recall D-1190-2022. Retrieved 2026-07-18 from https://api.ai-analytics.org/recall/D-1190-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*